Company / PP&E per Share
LENZ Therapeutics, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.04
FY2025
5-year range
$0.03 / $0.41
FY2021-FY2025
Trend
+41.2%
vs FY2024
Sector context
#124 of 191
Health Care
What the data says
At $0.04, LENZ Therapeutics, Inc.'s pp&e per share ranks #124 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 6 years, ranging from $0.03 in FY2023 to $0.64 in FY2020.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -41.7%.
Improved from $0.03 to $0.04 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -52.9%
- 5-Year CAGR
- -41.7%
- 10-Year CAGR
- -
Sector benchmark
#124 of 191 in Health CareTop 65% of 191This company $0.04 Sector average $22.34
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 41.2% year-over-year.
- Ranks #124 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
- Lowest pp&e per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +41.2% |
| FY2024 | $0.03 | +11.0% |
| FY2023 | $0.03 | -93.3% |
| FY2022 | $0.41 | +83.3% |
| FY2021 | $0.23 | -64.8% |
| FY2020 | $0.64 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026